Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ZOBRIUS PHARMA AS
AS
Active
Org 914330009
1. Strøm Terrasse 24A, 3046
Drammen
Manufacture of other food products n.e.c.
·
NACE 1089
Est. 2014 · 11 years old
1 employees
Overvåg
Share
Norway
/
Companies
/
Manufacture of other food products n.e.c.
/
ZOBRIUS PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
SA
Steinar Ask Magnussen
Chief Executive Officer
Chief Executive Officer
2015
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (4)
SA
Sverre Arne Slaastad
Board of Directors
Board of Directors
2022
GS
Grethe Støa Birketvedt
Board of Directors
Board of Directors
2022
BS
Børge Skjerven Nygårdshaug
Board of Directors
Board of Directors
2022
JJ
Jack Jensen
Board of Directors
Board of Directors
2025
Former (2)
AH
Arvid Helge Lindberg
Board of Directors
Board of Directors
2021 – 2022
AG
Astrid Green
Board of Directors
Board of Directors
2022 – 2025
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Jack J Holding As
Company
15.11%
15.11%
2025
Pharma Partner As
Company
10.03%
10.03%
2025
Bjørn Tore Langeland
Individual
9.44%
9.44%
2025
Bioactiva Diagnostica Gmbh
Company
8.48%
8.48%
2025
Norberg & Partner Sustainable Group
Company
6.2%
6.2%
2025
Rolf Tore Langeland
Individual
5.57%
5.57%
2025
Bsn Invest As
Company
4.53%
4.53%
2025
Slaastad Management Consultant As
Company
4.04%
4.04%
2025
Vassbygda Industrier As
Company
3.24%
3.24%
2025
Amir Mahbod Ahmati
Company
3.24%
3.24%
2025
Cross As
Company
3.02%
3.02%
2025
Inger Krogvig
Individual
1.83%
1.83%
2025
Henning Stene
Individual
1.73%
1.73%
2025
Alpha Eiendom Oslo As
Company
1.7%
1.7%
2025
Medisinsk Senter For Overvekt Og Forskning As
Company
1.64%
1.64%
2025
Rodin & Partner Ab
Company
1.51%
1.51%
2025
Randi Tordis Skogstad Fredriksen
Individual
1.3%
1.3%
2025
Magua As
Company
1.3%
1.3%
2025
Karl Invest As
Company
1.21%
1.21%
2025
Einar Langseth
Individual
1.18%
1.18%
2025
Einar Paul Helge Jensen
Individual
1.01%
1.01%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ZOBRIUS PHARMA AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network